BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10527627)

  • 21. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
    Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
    Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth defects in mouse telomerase RNA-deficient cells expressing a template-mutated mouse telomerase RNA.
    Marie-Egyptienne DT; Brault ME; Nimmo GA; Londoño-Vallejo JA; Autexier C
    Cancer Lett; 2009 Mar; 275(2):266-76. PubMed ID: 19056167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
    Goldkorn A; Blackburn EH
    Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth.
    Cassar L; Li H; Pinto AR; Nicholls C; Bayne S; Liu JP
    Cancer Res; 2008 Nov; 68(22):9157-66. PubMed ID: 19010887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
    Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
    Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line.
    Steenbergen RD; Kramer D; Meijer CJ; Walboomers JM; Trott DA; Cuthbert AP; Newbold RF; Overkamp WJ; Zdzienicka MZ; Snijders PJ
    J Natl Cancer Inst; 2001 Jun; 93(11):865-72. PubMed ID: 11390536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New function of CDC13 in positive telomere length regulation.
    Meier B; Driller L; Jaklin S; Feldmann HM
    Mol Cell Biol; 2001 Jul; 21(13):4233-45. PubMed ID: 11390652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
    Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
    Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and suppression of human telomerase RNA.
    Li S; Blackburn EH
    Cold Spring Harb Symp Quant Biol; 2006; 71():211-5. PubMed ID: 17381299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
    Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
    Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress.
    Rubio MA; Davalos AR; Campisi J
    Exp Cell Res; 2004 Aug; 298(1):17-27. PubMed ID: 15242758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional evidence for a squamous cell carcinoma mortality gene(s) on human chromosome 4.
    Forsyth NR; Morrison V; Craig NJ; Fitzsimmons SA; Barr NI; Ireland H; Gordon KE; Dowen S; Cuthbert AP; Newbold RF; Bryce SD; Parkinson EK
    Oncogene; 2002 Aug; 21(33):5135-47. PubMed ID: 12140764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
    Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
    Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3.
    Ohmura H; Tahara H; Suzuki M; Ide T; Shimizu M; Yoshida MA; Tahara E; Shay JW; Barrett JC; Oshimura M
    Jpn J Cancer Res; 1995 Oct; 86(10):899-904. PubMed ID: 7493906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased life span of human osteoarthritic chondrocytes by exogenous expression of telomerase.
    Piera-Velazquez S; Jimenez SA; Stokes D
    Arthritis Rheum; 2002 Mar; 46(3):683-93. PubMed ID: 11920404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region.
    Tanaka H; Shimizu M; Horikawa I; Kugoh H; Yokota J; Barrett JC; Oshimura M
    Genes Chromosomes Cancer; 1998 Oct; 23(2):123-33. PubMed ID: 9739015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extinction of albumin gene expression in a panel of human chromosome 2 microcell hybrids.
    Cerosaletti KM; Fournier RE
    Genomics; 1996 Feb; 31(3):348-58. PubMed ID: 8838317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase-independent senescence of human immortal cells induced by microcell-mediated chromosome transfer.
    Tanaka H; Horikawa I; Kugoh H; Shimizu M; Barrett JC; Oshimura M
    Mol Carcinog; 1999 Aug; 25(4):249-55. PubMed ID: 10449031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of
    Eberhard S; Valuchova S; Ravat J; Fulneček J; Jolivet P; Bujaldon S; Lemaire SD; Wollman FA; Teixeira MT; Riha K; Xu Z
    Life Sci Alliance; 2019 Jun; 2(3):. PubMed ID: 31160377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.